Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Unspecified time for visual acuity between 20/20 and 20/40	1		Odds Ratio (M-H, Fixed, 95% CI)	Totals not selected
2 Time to resolution of primary hemorrhage (days)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
3 Risk of secondary hemorrhage	1		Odds Ratio (M-H, Fixed, 95% CI)	Totals not selected
4 Time to rebleed (days)			Other data	No numeric data
5 Risk of glaucoma or elevated intraocular pressure (IOP)	1		Odds Ratio (M-H, Fixed, 95% CI)	Totals not selected
6 Adverse effects	1		Odds Ratio (M-H, Fixed, 95% CI)	Totals not selected
6.1 Nausea or vomiting	1		Odds Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6.2 Dizziness or hypotension	1		Odds Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6.3 Syncope	1		Odds Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6.4 Diarrhea	1		Odds Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6.5 Rash or pruritis	1		Odds Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6.6 Hot flashes	1		Odds Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6.7 Dry mouth or nose	1		Odds Ratio (M-H, Fixed, 95% CI)	0.0 [0.0, 0.0]
7 Duration of hospitalization (days)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected